The Impact of Ketamine on the Reward Circuitry of... — Clinical Trial Details

Participants

Ages

18 – 85

Sexes

Male & Female

BMI

0 - 35

Psychosis History

Inclusion Criteria

Inclusion Criteria:\n\nPatients will:\n\n1. be ≥18 years old,\n2. read, understand, and provide written informed consent,\n3. have suicidal ideation for ≥ 2 months, per the Columbia Suicide Severity Rating Scale (C-SSRS),\n4. be on a stable psychiatric medication regimen for ≥28 days,\n5. maintain a treating doctor who is in agreement with study participation, and aware of the safety plan in the protocol,\n6. have a reliable chaperone accompany them home following the completion of the ketamine infusion day,\n7. be generally healthy, as assessed by medical history, physical examination (including vital signs), clinical laboratory evaluations, and electrocardiogram (EKG),\n8. be of non-childbearing potential or use of an acceptable form of birth control (females only), and\n9. be right handed.\n\nHealthy Controls will:\n\n1. be ≥18 years old,\n2. read, understand, and provide written informed consent,\n3. have a negative pregnancy test on the morning of the MRI (females only).\n4. be right handed.

Exclusion Criteria

Exclusion Criteria (Patients):\n\n1. delirium or dementia diagnosis,\n2. unstable medical illness or clinically significant laboratory results,\n3. history of clinically significant cardiovascular disease or electrocardiogram (EKG) findings, or medical conditions that put the patient at risk for possible cardiac side effects or alter brain morphology (e.g., diabetes, hypertension, traumatic brain injury), even if well controlled on medications,\n4. history of multiple adverse drug reactions,\n5. active substance use disorders (except nicotine and caffeine) within the past six months, positive urine toxicology screen, or past history of ketamine/PCP abuse,\n6. requirement of excluded medications that may interact with ketamine (e.g., narcotics, barbiturates, sedatives, theophylline, or St. John's Wort),\n7. BMI >35,\n8. pregnancy, breastfeeding, or unacceptable means of birth control (females only)\n9. presence of MRI contraindications (e.g., presence of metallic (ferromagnetic) implants (e.g., heart pacemaker, aneurysm clips)),\n10. concurrent participation in other research studies.\n\nHealthy controls exclusion:\n\n1. current or past Axis I diagnosis, including alcohol or substance abuse or dependence diagnosis (except for nicotine or caffeine) and suicidal thoughts/attempts,\n2. presence of MRI contraindications (e.g., presence of metallic (ferromagnetic) implants (e.g., heart pacemaker, aneurysm clips)),\n3. presence of medical illness likely to alter brain morphology and/or physiology (e.g., diabetes) even if controlled by medications,\n4. requirement of excluded medications that may interact with ketamine (e.g., narcotics, barbiturates, benzodiazepines, sedatives, theophylline, or St. John's Wort),\n5. presence of psychiatric disorders in first-degree relatives,\n6. pregnancy, breastfeeding, or unacceptable means of birth control (females only), or\n7. BMI >35.

Company

Product

Legal

The Impact of Ketamine on the Reward Circuitry of Suicidal Patients

Detailed Description

Study Protocol

Preparation

Dosing

Locations

Integration

Study Arms & Interventions

Open-Label Ketamine

Interventions

Participants

Inclusion Criteria

Exclusion Criteria

Study Details

Study Team

Sponsors & Collaborators